Report content
Flag "Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial"
Help us keep the community safe by telling us why this story should be reviewed.
Article
By ByteScholar1503